1 completed, 1 not yet recruiting, 1 terminated, 1 withdrawn. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 1, Not yet recruiting 1, Terminated 1, Withdrawn 1 |
Follow Human Papillomavirus (HPV): new trials by email Literature Review of Human Papillomavirus (HPV) trials Research Report on Human Papillomavirus (HPV)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP) PRGN-2012, Bevacizumab - Respiratory Recurrent Papillomatosis (RRP), Human Papillomavirus (HPV) | Phase 2 | Not yet recruiting | National Cancer Institute (NCI) | 50 | 2026-11-04 | 2026-10-30 |
| RBD-HPV: Risk-Based De-Intensification for HPV+ HNSCC RT 50 Gy, RT 54 GY, RT 60 GY - Human Papillomavirus (HPV), Head and Neck Squamous Cell Carcinoma (HNSCC) | Phase 2 | Withdrawn | Icahn School of Medicine at Mount Sinai | 2022-06-14 | 2022-07-07 | |
| Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3) VGX-3100, Imiquimod 5% Cream, CELLECTRA™ 2000 - Vulvar High Grade Squamous Intraepithelial Lesion (HSIL), Vulvar Dysplasia | Phase 2 | Completed | Inovio Pharmaceuticals | 33 | 2017-08-31 | 2023-08-25 |
| AMG 319 in HPV Positive and Negative HNSCC AMG 319 hydrate, Placebo - Human Papillomavirus (HPV), Positive or Negative Head and Neck Squamous Cell Carcinoma (HNSCC) of the Hypopharynx, Oropharynx, Oral Cavity, Supraglottis or Larynx | Phase 2 | Terminated | Cancer Research UK | 35 | 2015-10-01 | 2018-07-18 |
Laryngeal Diseases (2) · Squamous Cell Carcinoma of Head and Neck (2) · Papillomavirus Infections (1) · Recurrent respiratory papillomatosis (1) · Respiratory Tract Neoplasms (1) · Tracheal Diseases (1)
Neoplasms (3) · Neoplasms by Site (3) · Carcinoma (2) · Carcinoma, Squamous Cell (2) · Head and Neck Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Otorhinolaryngologic Diseases (2) · Respiratory Tract Diseases (2) · Communicable Diseases (1) · DNA Virus Infections (1) · Disease Attributes (1) · Genital Diseases (1) · Infections (1) · Pathologic Processes (1)
Bevacizumab (1) · Carboplatin (1) · Imiquimod (1) · Neoadjuvant Therapy (1) · Radiotherapy (1) · VGX-3100 (1)
Cancer Research UK (1) · Icahn School of Medicine at Mount Sinai (1) · Inovio Pharmaceuticals (1) · National Cancer Institute (NCI) (1)
United States (3) · United Kingdom (1)
Jeffrey Skolnik, MD (1) · Marshall Posner, MD (1) · Scott M Norberg, D.O. (1)